IL140778A0 - Pharmaceutical compositions comprising component b and a human growth factor - Google Patents

Pharmaceutical compositions comprising component b and a human growth factor

Info

Publication number
IL140778A0
IL140778A0 IL14077899A IL14077899A IL140778A0 IL 140778 A0 IL140778 A0 IL 140778A0 IL 14077899 A IL14077899 A IL 14077899A IL 14077899 A IL14077899 A IL 14077899A IL 140778 A0 IL140778 A0 IL 140778A0
Authority
IL
Israel
Prior art keywords
growth factor
human growth
component
pharmaceutical compositions
compound
Prior art date
Application number
IL14077899A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL140778A0 publication Critical patent/IL140778A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Vascular Medicine (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14077899A 1998-07-09 1999-07-02 Pharmaceutical compositions comprising component b and a human growth factor IL140778A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98112775 1998-07-09
PCT/EP1999/004605 WO2000002579A2 (en) 1998-07-09 1999-07-02 Component b as angiogenic agent in combination with human growth factors

Publications (1)

Publication Number Publication Date
IL140778A0 true IL140778A0 (en) 2002-02-10

Family

ID=8232248

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14077899A IL140778A0 (en) 1998-07-09 1999-07-02 Pharmaceutical compositions comprising component b and a human growth factor
IL140778A IL140778A (en) 1998-07-09 2001-01-08 Pharmaceutical compositions comprising component b and a human growth factor

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140778A IL140778A (en) 1998-07-09 2001-01-08 Pharmaceutical compositions comprising component b and a human growth factor

Country Status (12)

Country Link
US (2) US6855684B2 (xx)
EP (1) EP1093380B1 (xx)
JP (1) JP2002520292A (xx)
AT (1) ATE224200T1 (xx)
AU (1) AU765600B2 (xx)
CA (1) CA2336773C (xx)
DE (1) DE69903037T2 (xx)
DK (1) DK1093380T3 (xx)
ES (1) ES2184480T3 (xx)
IL (2) IL140778A0 (xx)
PT (1) PT1093380E (xx)
WO (1) WO2000002579A2 (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE224200T1 (de) * 1998-07-09 2002-10-15 Applied Research Systems Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren
AU2001291019A1 (en) 2000-09-15 2002-03-26 Genvec, Inc. Method of modulating neovascularization
WO2004091646A2 (en) 2003-04-16 2004-10-28 Applied Research Systems Ars Holding, N.V. Use of slurp-1 for treating diseases related to acetylcholine receptors dysfunction
WO2006060803A2 (en) * 2004-12-03 2006-06-08 Polnox Corporation One pot process for making polymeric antioxidants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1257184B (it) * 1992-12-22 1996-01-10 Applied Research Systems Preparato ad attivita' antinfiammatoria, anticoagulante e antitumorale
US5998364A (en) * 1996-04-24 1999-12-07 Applied Research Systems Ars Holding N.V. Component B as cicatrizant
ATE224200T1 (de) * 1998-07-09 2002-10-15 Applied Research Systems Komponente b als angiogenes mittel zusammen mit humanen wachstumsfaktoren

Also Published As

Publication number Publication date
JP2002520292A (ja) 2002-07-09
AU765600B2 (en) 2003-09-25
IL140778A (en) 2008-03-20
ES2184480T3 (es) 2003-04-01
US20050153892A1 (en) 2005-07-14
US7223732B2 (en) 2007-05-29
WO2000002579A3 (en) 2000-02-24
CA2336773A1 (en) 2000-01-20
CA2336773C (en) 2009-12-15
US6855684B2 (en) 2005-02-15
US20010031733A1 (en) 2001-10-18
WO2000002579A2 (en) 2000-01-20
DK1093380T3 (da) 2003-01-27
ATE224200T1 (de) 2002-10-15
AU5030699A (en) 2000-02-01
DE69903037D1 (de) 2002-10-24
EP1093380B1 (en) 2002-09-18
EP1093380A2 (en) 2001-04-25
DE69903037T2 (de) 2003-06-05
PT1093380E (pt) 2003-01-31

Similar Documents

Publication Publication Date Title
DE3786879D1 (de) Bleichmittelzusammensetzungen, persaeure-glykolatester und prekursoren.
FI973828A (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
AP1450A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide.
AU2002231544A1 (en) Therapeutic uses of herbal compositions
BG106030A (en) Pharmaceutical composition
ES2178036T3 (es) Derivados de ciclosporina, su preparacion y las composiciones farmaceuticas que le contienen.
CA2294783A1 (fr) Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine
IL107870A0 (en) Pharmaceutical compositions having antidepressant activity comprising pramipexol
DK1167354T3 (da) Racemisk huperzin A
AU4830097A (en) Use of an extract of Cimicifuga
MX9204240A (es) Montaje distribuidor y de mezclado de dos etapas para preparaciones tal como cementos dentales.
IL146284A0 (en) Androgen glycosides and pharmaceutical compositions containing the same
IL140778A0 (en) Pharmaceutical compositions comprising component b and a human growth factor
AU5168493A (en) Ceramic reinforced dental appliances, devices and restorations
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
ITRM910430A1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
ATE58837T1 (de) Pharmazeutische zusammensetzungen zur verminderung der nebenwirkungen der anti-krebschemotherapie und erhoehung der immunitaet.
FI945439A (fi) Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät koostumukset
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
WO1999056697A3 (en) Pharmaceutical composition
AP1691A (en) A pharmaceutical composition comprising therapeutically effective quantities of calcium channel blockers in combination with quinolines.
ATE216254T1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
MD1473G2 (ro) Remediu antiherpetic
ZA934741B (en) New derivatives of 10-deacetylbaccatin III, their preparation and pharmaceutical compositions containing them.
DE60039122D1 (de) 6-o-alkyl-2-nor-2-substituierte ketolidderivate

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed